Provista Dx Raises $3.9M | GenomeWeb

NEW YORK (GenomeWeb) – Proteomics-based diagnostics firm Provista Diagnostics has raised $3.9 million, it said in a regulatory document filed on Monday. 

The Scottsdale, Ariz.-based firm did not respond to requests for comment. In a document filed with the US Securities and Exchange Commission, Provista said that there were 24 investors in the private offering of equity. It did not say how the funds would be used. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.